We are live on ! Find out more
CRL icon

Charles River Laboratories
CRL

225 hedge funds and large institutions have $1.93B invested in Charles River Laboratories in 2013 Q2 according to their latest regulatory filings, with 225 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

170% more call options, than puts

Call options by funds: $15.5M | Put options by funds: $5.73M

96.05% more ownership

Funds ownership: 0% → 96.05% (+96%)

Holders
225
Holders Change
+225
Holders Change %
–
% of All Funds
7.32%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
225
Increased
–
Reduced
–
Closed
–
Calls
$15.5M
Puts
$5.73M
Net Calls
+$9.73M
Net Calls Change
+$9.73M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

CRL Hedge Fund Activity: Q2 2013 in Review

225 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q2 2013, worth a combined $1.93B.

Buyers outnumbered sellers: 225 funds opened new CRL positions and 0 closed out — a net gain of 225 holders — while 0 added to existing stakes and 0 trimmed.

  • 225 institutional investors held Charles River Laboratories (CRL) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.93B of Charles River Laboratories stock for Q2 2013.
  • 225 funds opened new Charles River Laboratories positions in Q2 2013 and 0 closed out, a net change of +225 holders.

Based on aggregated 13F filings for Q2 2013.